Continuous renal replacement therapy is designed to function similarly to natural kidneys by continuously removing waste ...

In June 2024, EPKINLY monotherapy was granted accelerated approval by the FDA for the treatment of R/R FL following two or more lines of systemic therapy. With the results from the confirmatory Phase ...

Company AnnouncementEPKINLY plus rituximab and lenalidomide (EPKINLY + R2) is the first and only bispecific-based therapy approved by the FDA for ...

Co-Diagnostics, Inc. (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has begun ...

NIPPV is a treatment where a machine is used to help the person breathe. During NIPPV therapy, the person breathes using a mask that forces the air into the lungs, keeping the airways open and ...

The India Ceftriaxone Market is poised for growth due to rising infectious diseases, increased hospital admissions, and ...

A new study from Johns Hopkins Medicine offers hospitals a glimpse of how artificial intelligence (AI) could make prevention ...

A new AHA Trailblazers report, “Small Things Matter in Infection Prevention,” explores how hospitals are expanding surveillance programs to include peripheral intravenous catheters (PIVCs) and other ...

The United States is facing a demographic shift as the population of older adults grows rapidly, with the proportion of ...

Local infrastructure risks may include aging water systems, deteriorating roads, crumbling bridges, and outdated drainage networks, which could undermine even the most carefully developed emergency ...